Toward an understanding of polyglutamine neurodegeneration.
Polyglutamine expansion is now recognized to be a major cause of inherited human neurodegenerative disease. The polyglutamine expansion diseases identified so far are slowly progressive disorders in which distinct yet overlapping brain regions are selectively vulnerable to degeneration. Despite their clinical differences these diseases likely share a common pathogenic mechanism, occurring at the protein level and centered on an abnormal conformation of expanded polyglutamine in the respective disease proteins. Recently there has been remarkable progress in our understanding of polyglutamine disease, but still there are many unanswered questions. In this review, I first outline some of the shared features of polyglutamine diseases and then discuss several issues relevant to an understanding of pathogenesis, paying particular attention to possible mechanisms of neurotoxicity.
Paulson
H L
HL
Department of Neurology, University of Iowa College of Medicine, Iowa City 52242, USA. henry-paulson@uiowa.edu
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D016923:Cell Death / Q000502:physiology; D006801:Humans; D009154:Mutation / Q000502:physiology; D019636:Neurodegenerative Diseases / Q000235:genetics* / Q000503:physiopathology; D009474:Neurons / Q000502:physiology; D010455:Peptides / Q000737:chemistry / Q000235:genetics*; D011487:Protein Conformation
D010455:Peptides; C097188:polyglutamine